Iodine deficiency in Azerbaijan after the discontinuation of an iodine prophylaxis program: reassessment of iodine intake and goiter prevalence in schoolchildren.
The goal of this study was to assess the prevalence of iodine deficiency (ID) in Azerbaijan after the discontinuation of an iodine prophylaxis program by assessing the prevalence of goiter, iodine intake, and thyroid function. The study included 942 schoolchildren (475 boys and 467 girls) ages 8-14 years, from 13 distinct regions. The survey included the following: (1) clinical evaluation; (2) assessment of thyroid volume both by ultrasound and by palpation; (3) determination of iodide in a morning urine specimen using the classic Sandel-Kolthoff reaction in 347 schoolchildren; (4) determinations of thyrotropin (TSH), triiodothyronine (T3), thyroxine (T4), thyroglobulin (Tg), and anti-thyroid peroxidase (TPO) in serum (n = 165) and TSH in whole blood spotted on filter paper (n = 942). The prevalence of goiter for the whole country was determined by ultrasound (US) to be 86% and by palpation 66%, reaching 100% in the mountainous regions of Caucasus. The median urinary iodine excretion (UIE) was 54 microg/L, reaching level of 26 and 39 microg/L in the Caucasus region. In conclusion, according to the World Health Organization (WHO) classification, Azerbaijan now has mild to moderate ID (median UIE, 54 microg/L) and in the mountainous regions with severe ID. The high prevalence of goiter and the low UIE emphasizes the need for urgent medical reintervention. An iodination program is now implemented by our team in the mountainous regions under the auspice of the government of Azerbaijan.
Markou
K B
KB
Department of Medicine, University of Patras Medical School, University Hospital, Greece.
Georgopoulos
N A
NA
Makri
M
M
Anastasiou
E
E
Vlasopoulou
B
B
Lazarou
N
N
Deville
L
L
Megreli
C
C
Vagenakis
G A
GA
Sakellaropoulos
G C
GC
Jabbarov
R
R
Kerimova
M G
MG
Mamedgasanov
R M
RM
Vagenakis
A G
AG
D000293:Adolescent; D001323:Autoantibodies / Q000097:blood; D001382:Azerbaijan / Q000453:epidemiology; D002648:Child; D005260:Female; D006042:Goiter / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007453:Iodide Peroxidase / Q000276:immunology; D007454:Iodides / Q000652:urine; D007455:Iodine / Q000008:administration & dosage* / Q000172:deficiency*; D008297:Male; D010173:Palpation; D013954:Thyroglobulin / Q000097:blood; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000473:pathology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D014463:Ultrasonography
D001323:Autoantibodies; D007454:Iodides; D014284:Triiodothyronine; D013972:Thyrotropin; D013954:Thyroglobulin; D007455:Iodine; D007453:Iodide Peroxidase; D013974:Thyroxine